High Throughput Screening (HTS) Market Is Rising At A CAGR Of 7.89% By 2025: Grand View Research, Inc.

Posted on 2018-09-26 by researchinsights in Biotech, Healthcare, Pharmaceuticals // 0 Comments

San Francisco, United States, 2018-Sep-26 — /EPR Network/ —The global high throughput screening market size is expected to generate a revenue of USD 30.91 billion by 2025, according to a new report by Grand View Research, Inc., exhibiting a CAGR of 7.89% during the forecast period. Increasing adoption of faster and accurate technology by pharmaceutical companies to introduce newer molecules in the market is anticipated to provide a significant push to the market.

High throughput screening is used for testing of molecules in development phase on various grounds such as chemical, pharmaceutical, and genetic reactions. These screenings help in drug design and development based on real time results and near natural conditions that mimic natural reactions between the molecule and the body.

Moreover, this method can be fully automated using required hardware and software capable of handling a fully automated process along with data storage units that store and process considerable amount of data in short span of time.

As of 2016, approximately 55.0% of high throughput screening tests are carried out based on the cell based assays. Cell based assays are used majorly owing to the results that can be obtained at cellular levels along with pathways and mechanism.

These assays range from cytotoxic tests, including apoptosis, to cell metabolic assays. One more major technology implantation is the introduction of 3D – cell culture, which can help mimic natural conditions that give more accurate results and reactions to tests carried on. This trend is estimated to support the growth of the market during the forecast period.

To request a sample copy or view summary of this report:
www.grandviewresearch.com/industry-analysis/high-throughput-screening-market

Further key findings from the study suggest:

The market is driven by increasing competition between pharmaceutical companies to introduce novel molecules
Emerging 3D cell culture technology that provides better results in real time is set to boost the market
North America emerged as the clear hotspot for the development and adoption of this technology and had a major share in the market
Emerging regions such as Asia Pacific and Latin America are set to witness considerable growth in demand over the forecast period driven by the need of newer molecules to cure various diseases
Some of the key players in this market are Agilent Technologies, Inc., Danaher Corporation, Thermofisher Scientific, Inc., PerkinElmer, Inc. and Tecan Group Ltd., Merck Millipore, Bio-Rad laboratories, Hamilton Company, Axxam S.p.A., and Aurora Biomed.

Related Report of Biotechnology:

Grand View Research has segmented the global high throughput screening market by technology, application, and region:

High Throughput Screening Technology Outlook (Revenue, USD Billion, 2014 – 2025)

Cell-based Assays
- Fluorometric Imaging Plate Reader Assays

- - Clinical applications (Cardiotoxicity assays)
  - In-vitro studies (Pharmacophores identification in drug discovery)
- Reporter based Assays
  - Clinical applications (Reporter assay in biological systems analysis)
  - In-vitro studies (Genetic reporter assays in cloning tools for live-cell work)
3D – Cell Cultures
- Clinical applications (Regenerative medicine)
- In-vitro studies (Drug discovery, Molecular cell biology)
Ultra High Throughput Screening

High Throughput Screening Application Outlook (Revenue, USD Billion, 2014 – 2025)

Drug discovery programs
Chemical biology programs
Biochemical screening
Cell- & organ-based screening

High Throughput Screening Regional Outlook (Revenue, USD Billion, 2014 – 2025)

North America
- U.S.
- Canada
Europe
- Germany
- U.K
Asia Pacific
- China
- Japan
Latin America
- Brazil
MEA
- South Africa

Access Press Release Of This Research Report by Grand View Research: www.grandviewresearch.com/press-release/global-high-throughput-screening-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Matched content

Editor’s pick